DONNAMARIE MARTOCCI: Open Payments
NPI 1972085819 · LATHAM, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,521 in 63 payments from 17 companies in 2025. Trend: 2023 $483 · 2024 $795 · 2025 $1,521
Food & beverage: $1,521
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $438 |
| Lilly USA, LLC | 8 | $164 |
| Phathom Pharmaceuticals, Inc. | 3 | $154 |
| Gilead Sciences, Inc. | 2 | $139 |
| Abbott Laboratories | 5 | $101 |
| SANOFI-AVENTIS U.S. LLC | 2 | $86 |
| Novo Nordisk Inc | 4 | $86 |
| AstraZeneca Pharmaceuticals LP | 4 | $69 |
| GlaxoSmithKline, LLC. | 3 | $63 |
| Astellas Pharma US Inc | 2 | $51 |
Products named: UBRELVY, VOQUEZNA, QULIPTA, Yeztugo, ZEPBOUND, FREESTYLE LIBRE 3, TZIELD, JARDIANCE.
Industry payments across NY — which companies pay providers there.
